Details for 2020743773
Up to date per 03.04.2026
Actions
Details for 2020743773
Granted/Registered
European Patent
27.04.2022 A
15.11.2023 B1
18.06.2019
US
201962863199 P
24.12.2019
US
201962953223 P
15.05.2020
US
202063025278 P
C07D 413/06 20060101AFI20201225BHEP
Owner
Pfizer Inc.66 Hudson Boulevard East New York, NY 10001-2192US
CTXT PTY LTD305 Grattan Street Parkville Melbourne, VIC 3000AU
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
BOZIKIS, Ylva Elisabet Bergmanc/o Monash Institute of Pharmaceutical Sciences 381 Royal Parade Parkville, Victoria 3052AU
BRODSKY, Olegc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
CAMERINO, Michelle Angc/o Monash Institute of Pharmaceutical Sciences 381 Royal Parade Parkville, Victoria 3052AU
GREASLEY, Samantha Elizabethc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
HOFFMAN, Robert Louisc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
KUMPF, Robert Arnoldc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
KUNG, Pei-Peic/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
RICHARDSON, Paul Francisc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
STUPPLE, Paul Anthonyc/o Monash Institute of Pharmaceutical Sciences 381 Royal Parade Parkville, Victoria 3052AU
SUTTON, Scott Channingc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US
Information about Fees